Soo Wan Kim Selected Research

Soo Wan Kim Research Topics

Disease

51	Chronic Renal Insufficiency 02/2024 - 01/2011
28	Hypertension (High Blood Pressure) 12/2023 - 04/2002
28	Fibrosis (Cirrhosis) 11/2022 - 11/2005
20	Chronic Kidney Failure (Chronic Renal Failure) 04/2024 - 04/2011
19	Acute Kidney Injury (Acute Renal Failure) 03/2023 - 06/2007
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 08/2009
16	Ureteral Obstruction 01/2023 - 10/2001
15	Inflammation (Inflammations) 04/2022 - 02/2010
11	Proteinuria 01/2024 - 05/2004
11	Kidney Diseases (Kidney Disease) 01/2023 - 01/2013
10	Myocardial Infarction 01/2024 - 01/2011
10	Renal Insufficiency (Renal Failure) 11/2023 - 01/2007
10	Neoplasms (Cancer) 11/2022 - 02/2012
8	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2020 - 05/2004
7	Ascites 08/2010 - 05/2004
6	Infections 01/2022 - 04/2005
5	Hyponatremia 09/2021 - 06/2007
5	Peritonitis 01/2019 - 06/2012
5	Polyuria 01/2019 - 10/2005
4	Vascular Calcification 04/2024 - 02/2017
4	Fabry Disease (Fabry's Disease) 01/2024 - 01/2012
4	Ischemia 05/2023 - 06/2007
4	Abdominal Obesity 01/2023 - 01/2014
4	Hypernatremia 08/2022 - 11/2006
4	Hereditary Nephritis (Alport Syndrome) 05/2021 - 08/2019
4	Albuminuria 04/2021 - 01/2014
4	Hypoalbuminemia 03/2019 - 05/2004
4	Acidosis 04/2012 - 12/2007
3	Death (Near-Death Experience) 01/2024 - 10/2012
3	Wounds and Injuries (Trauma) 05/2023 - 04/2005
3	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2023 - 12/2018
3	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2021
3	Vitamin D Deficiency 01/2023 - 07/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 11/2005
3	Nephrogenic Diabetes Insipidus 08/2022 - 01/2009
3	Diabetes Mellitus 01/2022 - 04/2005
3	Anemia 01/2021 - 01/2013
3	Obesity 01/2021 - 02/2020
3	Exanthema (Rash) 07/2020 - 10/2012
3	Hyperuricemia 03/2020 - 12/2017

Drug/Important Bio-Agent (IBA)

22	SodiumIBA 01/2023 - 05/2004
17	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2005
17	CreatinineIBA 01/2023 - 12/2007
14	omega-Chloroacetophenone (Mace)IBA 04/2024 - 08/2009
14	SaltsIBA 01/2023 - 04/2002
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
9	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2013 - 04/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2020 - 04/2010
6	AdiponectinIBA 12/2023 - 06/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2014
6	PotassiumIBA 01/2023 - 04/2014
6	Uric Acid (Urate)IBA 09/2021 - 12/2017
6	Acetates (Acetic Acid Esters)FDA Link 12/2012 - 12/2007
6	Desoxycorticosterone (Deoxycorticosterone)IBA 12/2012 - 12/2007
6	Atrial Natriuretic Factor (ANF)IBA 10/2011 - 04/2002
5	MineralsIBA 04/2024 - 03/2014
5	OsteoprotegerinIBA 02/2024 - 01/2016
5	EnzymesIBA 01/2024 - 01/2012
5	AcidsIBA 01/2022 - 08/2008
5	Angiotensin Receptor AntagonistsIBA 05/2021 - 09/2012
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2021 - 09/2012
5	Vasopressins (Vasopressin)IBA 01/2019 - 06/2007
4	GalactosidasesIBA 01/2024 - 01/2012
4	CholesterolIBA 12/2023 - 01/2014
4	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 10/2019
4	HDL CholesterolIBA 11/2022 - 01/2019
4	AngiotensinogenIBA 10/2022 - 01/2019
4	CalciumIBA 12/2021 - 12/2011
4	Fibronectins (Fibronectin)IBA 01/2021 - 01/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2020 - 01/2007
4	Angiotensin IIIBA 02/2020 - 01/2009
4	AngiotensinsIBA 03/2018 - 11/2002
4	Gentamicins (Gentamicin)FDA LinkGeneric 12/2014 - 02/2010
4	AldosteroneIBA 01/2014 - 03/2006
4	Puromycin AminonucleosideIBA 08/2010 - 05/2004
4	Endothelin-1 (Endothelin 1)IBA 04/2010 - 06/2008
4	Aquaporins (Water Channels)IBA 01/2009 - 10/2001
4	Epithelial Sodium ChannelsIBA 12/2007 - 11/2005
3	ChloridesIBA 07/2023 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 05/2023 - 10/2002
3	Tolvaptan FDA Link 03/2023 - 04/2018
3	LipidsIBA 01/2023 - 06/2016
3	VimentinIBA 05/2022 - 11/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 09/2009
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2018
3	C-Reactive ProteinIBA 01/2021 - 01/2014
3	Serine (L-Serine)FDA Link 05/2020 - 01/2009
3	N1- (3- (dimethylamino)propyl)- N8- hydroxy- 2- ((naphthalene- 1- loxy)methyl)oct- 2- enediamideIBA 02/2020 - 01/2018
3	Histone Deacetylase InhibitorsIBA 02/2020 - 01/2018
3	Histone Deacetylases (Histone Deacetylase)IBA 02/2020 - 01/2013
3	Fibroblast Growth Factor-23IBA 01/2020 - 02/2017
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2019

Therapy/Procedure

15	Renal Dialysis (Hemodialysis) 12/2021 - 04/2005
13	Therapeutics 01/2023 - 01/2012
10	Kidney Transplantation 03/2023 - 04/2012
7	Peritoneal Dialysis 04/2021 - 04/2011
7	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2019 - 06/2002
5	Percutaneous Coronary Intervention 01/2022 - 01/2012
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2024 - 10/2019
3	Continuous Renal Replacement Therapy 12/2023 - 06/2008